# Lancet Commission on Hearing Loss-CTSA Administrative Supplement

> **NIH NIH UL1** · DUKE UNIVERSITY · 2020 · $581,500

## Abstract

The mission of the Duke Clinical and Translational Science Institute is to catalyze the translation of
scientific discoveries into population health benefits through collaborative research. With previous Clinical
and Translational Science Award (CTSA) funding, we have successfully developed infrastructure and
provided resources to support investigators across the clinical and translational scientific and workforce
spectrums. Our achievements have facilitated high-impact discoveries, increased research efficiency, and
nurtured a more capable and diverse workforce. We have also ignited a new era of collaborative science
at Duke. Several new transdisciplinary programs have been launched, connecting trainees and faculty
from our Schools of Medicine, Nursing, Engineering, Business, and Arts and Sciences to enhance
translation. In the next phase, Duke proposes to capitalize on new opportunities with three broad
initiatives. First, we will optimize clinical and translational science national networks’ methods and
processes. Building on Duke’s leading experience coordinating multi-center clinical trials including its
national Duke-Vanderbilt NCATS Trial Innovation Center, we will develop methods to optimize ‘local hub,’
‘hub-to-network’ and ‘network-to-network’ processes for the NCATS Trial Innovation Network. We will also
help investigators leverage a number of additional NIH network resources and provide methods to
disseminate best practices throughout the CTSA network. Second, we will deepen, nurture, and extend
stakeholder collaborations. We will strengthen existing partnerships and foster new ones with
stakeholders at both the institutional and investigator levels. Partnerships and programs will expand the
breadth and transparency of CTSI activities. We will also support investigators’ greater engagement with
a broad range of patients, community groups, clinicians, health care systems, industry, venture
capitalists, payers, policy makers, and others. Third, we will catalyze further science integration at Duke.
An invigorated professional workforce will facilitate major transdisciplinary science initiatives. A new
University-wide coordination infrastructure will further amplify collaboration and bridge science siloes. We
will also support teams by improving their skills in team science, studying team processes, and by
promoting the recognition of team contributions at our institution. Collectively, these activities will amplify
the innovation and impact of our research nationally, regionally, and locally. We will measure outcomes
that reflect improvement in the translation of discoveries, use of national best practices, institutional and
investigator teamwork, research transparency, and community trust. We will share all best practices with
the CTSA network. We believe our achievements will meaningfully enhance the impact of clinical and
translational science on health across the United States. The following proposal is for an Administrative
Suppleme...

## Key facts

- **NIH application ID:** 10190037
- **Project number:** 3UL1TR002553-03S3
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** Leigh E Boulware
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $581,500
- **Award type:** 3
- **Project period:** 2020-06-13 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10190037

## Citation

> US National Institutes of Health, RePORTER application 10190037, Lancet Commission on Hearing Loss-CTSA Administrative Supplement (3UL1TR002553-03S3). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10190037. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*